Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Alcohol lobby takes on WHO in battle over health impacts
    Finance

    Alcohol lobby takes on WHO in battle over health impacts

    Published by Global Banking & Finance Review®

    Posted on September 24, 2025

    6 min read

    Last updated: January 21, 2026

    Alcohol lobby takes on WHO in battle over health impacts - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:public policyhealthcarefinancial stabilityconsumer protection

    Quick Summary

    The alcohol industry is lobbying against WHO's stance on drinking risks, affecting U.N. health agreements. Industry claims moderate drinking is low-risk.

    Table of Contents

    • Industry Response to WHO Health Guidelines
    • Lobbying Efforts by Alcohol Producers
    • Changes in U.N. Health Agreement
    • Arguments for Moderate Drinking
    • Challenges in Health Messaging

    Global Alcohol Industry Challenges WHO's Stance on Drinking Risks

    Industry Response to WHO Health Guidelines

    (Corrects September 24 story to remove misinterpreted quote from IARD CEO Braithwaite, adds fresh quote from the same interview in paragraph 7)

    By Emma Rumney and Jennifer Rigby

    LONDON (Reuters) -The Belgian beer industry, Mexico's tequila makers and Heineken all lobbied governments this summer to resist a push by the U.N.'s health agency to introduce tougher rules targeting alcohol, letters and an email reviewed by Reuters show.

    Lobbying Efforts by Alcohol Producers

    The previously unreported efforts reflect how the $1 trillion global drinks industry is taking on the World Health Organization over its hardening stance that there is no risk-free level of drinking.

    That position is disputed by the industry. And as cash-strapped and increasingly health-conscious consumers cut back on alcohol, dealing a blow to companies' profits, the stand-off reveals how the sector is ramping up its efforts to head off further threats. 

    ALCOHOL POLICIES WATERED DOWN IN UN HEALTH AGREEMENT

    The WHO and other health authorities say drinking, sometimes even in small amounts, is linked to higher risks of certain cancers and other diseases.

    Dag Rekve, the WHO's technical policy officer, told Reuters that at the population level, these health harms were "consistent and well documented".

    But alcohol makers say the science is more complicated, and shows drinking in moderation is low-risk. Julian Braithwaite, CEO of the International Alliance for Responsible Drinking (IARD), told Reuters the industry aims to become "more engaged... more vocal" in the debate.

    To that end, IARD's members, which include leading brewers and spirit makers, have increased the organisation's funding to have it play a more active role in alcohol-related science debates and counter the message coming from health bodies.

    Changes in U.N. Health Agreement

    The current flashpoint in that battle is a new U.N.-backed agreement, due for adoption by countries on September 25, that sets targets for tackling non-communicable diseases, some of them linked to alcohol.

    Proposed WHO-backed alcohol controls appeared in the first draft of the agreement published in May. But a later version, from earlier in September, also public, shows they have been dropped or weakened.

    The WHO said last week that the process had been affected by intense lobbying, including by the alcohol industry. 

    A letter seen by Reuters shows that, in May, soon after the first draft of the agreement was released, Mexico's National Chamber of the Tequila Industry (CNIT), which represents top spirits makers, wrote to the Mexican government. 

    CNIT asked Mexican authorities to use talks with other governments to help remove references to WHO-supported policies, including commitments to raise taxes on alcohol and restrict its availability in stores, the letter showed.

    Those proposals were subsequently tempered in the September draft to say countries should "consider" introducing tax increases "in line with national circumstances" and "consider ... availability measures."  

    A separate letter sent to the Mexican government on behalf of Dutch beer giant Heineken suggested changing a proposal to ban or restrict alcohol advertising to instead focus it on advertising to minors.

    Calls for restrictions on alcohol advertising were dropped from the September version of the agreement. 

    Trade association Belgian Brewers, meanwhile, wrote to the Belgian deputy prime minister's office in June complaining that the country's health minister was pursuing "radical positions" in relation to the U.N. text, an email seen by Reuters showed. 

    The industry group pointed to attempts to change a reference about reducing the impact of harmful consumption, such as alcohol addiction, into a statement that referred to all kinds of drinking. 

    Arguments for Moderate Drinking

    A SHIFT NEEDED?

    Heineken, CNIT and Belgian Brewers told Reuters it was standard practice to communicate industry views to policymakers. CNIT said it did not seek to weaken the U.N. agreement, only to ensure that it was both effective and fair to the industry by providing robust science, and added that this resulted in better policies. 

    Both the Mexican chamber and Heineken said the private sector has a recognised role in the U.N. health process. 

    Belgian Brewers, meanwhile, said a shift to focus on all alcohol consumption risked being counterproductive.

    It is not clear if the Mexican government adopted the industry's suggestions during negotiations over the U.N.-backed document. Mexico's health ministry did not respond to Reuters' questions. 

    IARD's Braithwaite said the changes made to the health targets reflected governments' recognition that an approach that distinguishes between moderate and harmful consumption, such as drink-driving, works.

    But Jeremy Farrar, the WHO's assistant-director general in charge of health promotion, disease prevention and care, said that the body had to address the main causes of ill health - from alcohol to pollution - more strongly.

    "There does have to be a shift," he told Reuters.

    Challenges in Health Messaging

    A BATTLE OF MESSAGES

    The WHO's headquarters and European office have increased the number of publications released relating to alcohol since 2022, according to a Reuters review of their output. And in 2023, they moved to a stance that there is "no safe level" of drinking. 

    Company executives have argued the industry needs to more actively push back and promote positive aspects of moderate drinking. 

    In March, Diageo advertised for a new role on its global lobbying team, citing "an unprecedented challenge" from the WHO and related non-governmental organisations pressuring governments. 

    Such roles are a "standard part of how we engage with governments to advocate for proportionate, evidence-based policies that support both society and business", a Diageo spokesperson said.

    Diageo interim CEO Nik Jhangiani said at a recent conference that the spirits sector was being "outshone" by negative messaging, and it should do more to manage the dialogue. 

    And Carlsberg CEO Jacob Aarup-Andersen told Reuters last month that moderate drinking has benefits for socialising and mental health and said the industry should communicate those.

    But health or policy arguments from drinks companies should be taken with a grain of salt, said Eric Crosbie, a professor at the University of Nevada, Reno's School of Public Health. 

    "We have to remember these are businesses," he said. "They're there to make money."

    (Reporting by Emma Rumney and Jennifer Rigby; Editing by Adam Jourdan and Joe Bavier)

    Key Takeaways

    • •The global alcohol industry is lobbying against WHO's drinking guidelines.
    • •Industry claims moderate drinking is low-risk, contrary to WHO's stance.
    • •U.N. health agreement proposals on alcohol controls were weakened.
    • •Mexican and Belgian alcohol producers actively resisted WHO policies.
    • •The debate highlights tensions between health guidelines and industry interests.

    Frequently Asked Questions about Alcohol lobby takes on WHO in battle over health impacts

    1What is the WHO's stance on alcohol consumption?

    The WHO states that there is no risk-free level of drinking and that even small amounts are linked to higher risks of certain cancers and other diseases.

    2How has the alcohol industry responded to WHO's guidelines?

    The alcohol industry disputes the WHO's position, arguing that moderate drinking can be low-risk and has increased its lobbying efforts to influence health policies.

    3What changes were made to the U.N.-backed health agreement?

    Proposed WHO-backed alcohol controls were initially included in the draft but were later dropped or weakened due to intense lobbying from the alcohol industry.

    4What role does the private sector play in the U.N. health process?

    Both the Mexican chamber and Heineken emphasized that the private sector has a recognized role in the U.N. health process, advocating for evidence-based policies.

    5What are the potential benefits of moderate drinking according to industry leaders?

    Industry leaders like Carlsberg's CEO argue that moderate drinking can have social and mental health benefits, suggesting that these positive aspects should be communicated more effectively.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostInvestor association VEB calls for court inquiry into Philips sleep apnea recall
    Next Finance PostEuropean defence stocks get boost from Trump's Ukraine comments